Ferric Citrate Tablets - BINOBAL Tablets

Composition:

Ferric Citrate 1g eq. to Ferric Iron 210mg
10*10 Alu-Alu

1,599.00

Share

Description

BINOBAL Tablets – Advanced Iron Supplement for CKD-Associated Anemia & Hyperphosphatemia.

BINOBAL Tablets – A powerful solution for managing anemia and hyperphosphatemia in Chronic Kidney Disease (CKD) patients.

BINOBAL Tablets – The contain Ferric Citrate, a dual-action agent that works both as a phosphate binder and iron supplement, designed specifically for CKD patients. It releases elemental iron for intestinal absorption, aiding in anemia management, while simultaneously binding dietary phosphate in the gastrointestinal tract to reduce its absorption—thereby supporting phosphate control.

Its high bioavailability and better GI tolerance make it a superior alternative to conventional iron salts like ferrous sulfate or ferrous fumarate, minimizing gastrointestinal discomfort.

KEY BENEFITS of Ferric Citrate Tablets – BINOBAL Tablets

✅High Bioavailability with Better GI Tolerance – Provides highly absorbable iron with fewer gastrointestinal side effects compared to conventional iron salts.
✅Improved Erythropoietin Efficiency – Enhances hemoglobin levels and reduces erythropoietin-stimulating agent (ESA) and IV iron requirements in dialysis patients.
✅Dual Benefit for Renal (CKD) Patients – Combination helps correct iron deficiency anemia and also acts as a phosphate binder that lowers serum phosphorus in chronic kidney disease (CKD) patients.

Recommended by Specialists:

👨‍⚕️Nephrologists: For comprehensive management of CKD-associated anemia and hyperphosphatemia in patients on or off dialysis.
👨‍⚕️Hematologists: For management of iron deficiency anemia in dialysis patients where oral iron with better tolerance is preferred.

INDICATIONS:

Iron Deficiency Anemia in CKD
Hyperphosphatemia in CKD
Anemia Management in Dialysis Patients

×

Hello!

Click one of our contacts below to chat on WhatsApp

× How can I help you?